AlphaTime Acquisition Corp Ordinary Shares (ATMC)vsDrugs Made In America Acquisition II Corp. Ordinary Shares (DMII)
ATMC
AlphaTime Acquisition Corp Ordinary Shares
$15.60
0.00%
FINANCIAL SERVICES · Cap: $38.02M
DMII
Drugs Made In America Acquisition II Corp. Ordinary Shares
$9.97
-0.10%
FINANCIAL SERVICES · Cap: $653.78M
Smart Verdict
WallStSmart Research — data-driven comparison
DMII leads profitability with a 0.0% profit margin vs 0.0%. DMII earns a higher WallStSmart Score of 23/100 (F).
ATMC
Avoid22
out of 100
Grade: F
DMII
Avoid23
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-2788.9%
Fair Value
$0.54
Current Price
$15.60
$15.06 premium
Intrinsic value data unavailable for DMII.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
No standout strengths identified
Areas to Watch
0.0% revenue growth
Smaller company, higher risk/reward
ROE of 2.0% — below average capital efficiency
0.0% margin — thin
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : ATMC
ATMC has a balanced fundamental profile.
Bull Case : DMII
DMII has a balanced fundamental profile.
Bear Case : ATMC
The primary concerns for ATMC are Revenue Growth, Market Cap, Return on Equity. A P/E of 186.3x leaves little room for execution misses.
Bear Case : DMII
The primary concerns for DMII are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
DMII is growing revenue faster at 0.0% — sustainability is the question.
ATMC generates stronger free cash flow (-5,067), providing more financial flexibility.
Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
DMII scores higher overall (23/100 vs 22/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
AlphaTime Acquisition Corp Ordinary Shares
FINANCIAL SERVICES · SHELL COMPANIES · USA
AlphaTime Acquisition Corp (ATMC) is a special purpose acquisition company (SPAC) focused on identifying and merging with innovative enterprises across high-growth sectors. Backed by a solid capital foundation and a seasoned management team, ATMC aims to maximize shareholder value through strategic partnerships with businesses that demonstrate substantial growth potential. By concentrating on emerging technology and evolving consumer trends, the company is positioned to create enduring value for its stakeholders while employing a disciplined evaluation process to navigate the dynamic landscape of mergers and acquisitions.
Drugs Made In America Acquisition II Corp. Ordinary Shares
FINANCIAL SERVICES · SHELL COMPANIES · USA
Drugs Made In America Acquisition II Corp. (DMII) is a special purpose acquisition company (SPAC) focused on merging with innovative firms within the pharmaceuticals and biotechnology sectors to enhance domestic drug manufacturing capabilities. Leveraging the extensive expertise of its management team, DMII identifies and executes strategic transactions that align with rising market demands and prioritize sustainable practices. Through its commitment to fostering resilient supply chains and advancing U.S. healthcare self-sufficiency, DMII aims to deliver sustained value for its shareholders and contribute to the long-term growth of the American pharmaceutical landscape.
Compare with Other SHELL COMPANIES Stocks
Want to dig deeper into these stocks?